Both FGF1 and FGF2 promote glucose uptake by human prostate cancer cells (Ye et al., 2024) and mouse adipocytes through the MEK/ERK pathway (Kihira et al., 2011; Nies et al., 2022). The gene discussed is FGF1; the disease is prostate carcinoma.